These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 28695567

  • 1. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
    Unkart JT, Hosseini A, Wallace AM.
    J Surg Oncol; 2017 Dec; 116(7):819-823. PubMed ID: 28695567
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
    Unkart JT, Proudfoot J, Wallace AM.
    Breast J; 2018 Jul; 24(4):526-530. PubMed ID: 29498443
    [Abstract] [Full Text] [Related]

  • 3. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.
    Baker JL, Pu M, Tokin CA, Hoh CK, Vera DR, Messer K, Wallace AM.
    Ann Surg Oncol; 2015 Jan; 22(1):40-5. PubMed ID: 25069859
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of Post-injection Site Pain Between Technetium Sulfur Colloid and Technetium Tilmanocept in Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy.
    Unkart JT, Baker JL, Hosseini A, Hoh CK, Wallace MS, Vera DR, Wallace AM.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S559-65. PubMed ID: 26275779
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 99mTc-Tilmanocept Versus 99mTc-Sulfur Colloid in Lymphoscintigraphy: Sentinel Lymph Node Identification and Patient-Reported Pain.
    Murphy BL, Woodwick AR, Murphy KM, Chandler KJ, Johnson GB, Hunt CH, Peller P, Jakub JW, Homb AC.
    J Nucl Med Technol; 2019 Dec; 47(4):300-304. PubMed ID: 31019032
    [Abstract] [Full Text] [Related]

  • 8. How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent.
    Eckhoff A, Farrow NE, Silvestri C, Stroobant E, Intenzo C, Leddy M, Tyler DS, Berger A, Beasley GM.
    J Surg Oncol; 2022 Mar; 125(4):712-718. PubMed ID: 34786720
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
    Wallace AM, Han LK, Povoski SP, Deck K, Schneebaum S, Hall NC, Hoh CK, Limmer KK, Krontiras H, Frazier TG, Cox C, Avisar E, Faries M, King DW, Christman L, Vera DR.
    Ann Surg Oncol; 2013 Aug; 20(8):2590-9. PubMed ID: 23504141
    [Abstract] [Full Text] [Related]

  • 11. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
    Leong SP, Kim J, Ross M, Faries M, Scoggins CR, Metz WL, Cope FO, Orahood RC.
    Ann Surg Oncol; 2011 Apr; 18(4):961-9. PubMed ID: 21331809
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study.
    Marcinow AM, Hall N, Byrum E, Teknos TN, Old MO, Agrawal A.
    JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):895-902. PubMed ID: 24051744
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sentinel Lymph Node Biopsy in Breast Cancer with 99mTc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer.
    Vidal-Sicart S, Rioja ME, Prieto A, Goñi E, Gómez I, Albala MD, Lumbreras L, León LF, Gómez JR, Campos F.
    J Nucl Med; 2021 May 10; 62(5):620-627. PubMed ID: 33037087
    [Abstract] [Full Text] [Related]

  • 19. Does 99mTc-tilmanocept, as next generation radiotracer, meet with the requirements for improved sentinel node imaging?
    Rietbergen DD, Pereira Arias-Bouda LM, van der Hage J, Valdés Olmos RA.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 May 10; 40(5):275-280. PubMed ID: 34425967
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.